While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the market? This article walks through what the current numbers may be telling ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Simplicity in logo design isn't lazy; it's strategic. A simple logo's job isn't to describe, but to identify. We break down 25 best examples from brands like Apple, FedEx, and Nike to uncover the core ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Simple keys in Hollow Knight: Silksong are used to open doors scattered around Pharloom, but they're few and far between. As you're exploring Silksong, you've probably come across a few locked doors.

Prove recursive verification of a simple program, like Fibonacci. Could be extended in the future to a more complex example suite, with programs like Keccak for instance.

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical success. The recent cull of programs has further undermined investor ...